INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
XJ
Xiao JinSr. Corporate VP, Engineering
SMCISuper Micro Computer, Inc.
Tax withholding
F$55K
1,436 sh
Aug 17, 2026Aug 19, 2026
Page 509 of 1717
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELL
traded Aug 17, 2026
+2d
SEC Form 4

Evidence

12
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Gift
G—
7,480 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

12
CL
Campbell Renee LSVP, Capital Markets & Risk
VMIVALMONT INDUSTRIES INC
Option exercise
M$212K
838 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

12
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Tax withholding
F$389K
12.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$17K
208 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
8,205 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
8,205 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
464 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$10K
130 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
8,205 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$23K
285 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$396K
5,066 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$31K
381 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$3,005
67 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

11
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$161K
10.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
485 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
231 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$37K
464 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$39K
485 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
870 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
340 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
SS
Slocum Jeffrey ShannonDirector, Director, EVP and COO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$566K
16.1K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
757 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$20K
243 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$18K
221 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
1,198 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
221 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$19K
231 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$27K
334 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$4,976
62 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$26K
325 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$12K
146 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Tax withholding
F$457K
15.8K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$270K
4,630 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
1,365 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$7,946
99 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
664 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

11
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$27K
340 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

10
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Gift · 10b5-1 plan
G—
16.8K sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

10
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$307K
31.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

MSIMotorola Solutions, Inc.Nov 6 – Nov 10
8 insiders$40.91M
  • SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M